Drug recall · August 16, 2017
Hydromorphone Hydrochloride Injection recall
Why: Presence of Particulate Matter: Silicone oil
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.
- Lots / codes
Lot #: 560103F, Exp. 01AUG2017
- Quantity
- 56,340 vials
- Company
- Hospira Inc, Lake Forest, Lake Forest, IL
- Distribution
- Nationwide in the USA
- Initiated
- July 26, 2017 · Voluntary: Firm initiated
- Classified
- August 9, 2017
- Reported
- August 16, 2017
- Ended
- May 11, 2018
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydromorphone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.